CTLA4 and cancer: Two predominant immune checkpoint pathways that have been extensively studied in cancers are those associated with cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) [16] and programmed cell death protein 1 (PD-1) [17,18].